Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Inovio announces regulatory approval for Phase 2 trial to treat leukemia using new vaccine delivery device

Inovio Pharmaceuticals, a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the regulatory approval of a Phase 2 clinical trial to treat leukemia utilizing Inovio's new ELGEN 1000 automated vaccine delivery device.

31 Jan 2011

$61 million anti-tobacco campaign launched to prevent lung cancer

The Australian Federal Government is backing a $61 million advertising campaign to stop smoking. This is the nation’s biggest anti-tobacco campaign. The message is graphic and simple: every cigarette brings cancer closer. Health groups have backed the campaign but advertising industry experts say the public has become increasingly immune to scare campaigns.

31 Jan 2011

Research Project's efficient solution for early cancer detection receives Leonardo da Vinci Prize

International philanthropists are challenging the world to provide a Cancer Research Project offering the most efficient solution in Particle Physics for early cancer detection with the highest potential to reduce premature cancer death.

29 Jan 2011

European Commission grants approval for Johnson & Johnson's proposed acquisition of Crucell

Johnson & Johnson and Crucell today announced that the European Commission has granted approval for Johnson & Johnson's proposed acquisition of Crucell.

29 Jan 2011

Research roundup: Barriers to trauma care, immunizations; Small business tax credit; Medicare coverage of preventive care

Possible Geographical Barriers To Trauma Center Access For Vulnerable Patients In The United States - This study analyzes disparities in geographic access to trauma centers in 2005, drawing from data from the 2005 American Hospital Association annual survey.

29 Jan 2011

Light therapy can help preserve vocal cord function for patients with early stage laryngeal cancer: Study

Light, or photodynamic, therapy can help preserve the voice and vocal cord function for patients with early stage laryngeal (voice box) cancer, according to a study from Henry Ford Hospital in Detroit.

29 Jan 2011

Nitrous oxide anesthesia may lead to increased risk of myocardial infarction: Study

Patients receiving nitrous oxide as part of general anesthesia for surgery may be at increased long-term risk of myocardial infarction (heart attack), reports a study in the February issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.

29 Jan 2011

Survey finds public lack knowledge of radiotherapy

Fewer than one in ten people think radiotherapy is a modern cancer treatment according to the results of a survey published Friday.

28 Jan 2011

Tarceva Phase III EURTAC study in NSCLC patients with EGFR activating mutations meets primary endpoint

Genentech, a member of the Roche Group and OSI Pharmaceuticals, a wholly owned subsidiary of Astellas U.S. Holding Inc., a holding company owned by Astellas Pharma Inc., today announced that an independent data monitoring committee has recommended that the Phase III EURTAC study be stopped early because the study met its primary endpoint.

28 Jan 2011

Preclinical data on Inovio’s intradermal electroporation delivery devices presented at Phacilitate Vaccine Forum

Inovio Pharmaceuticals, Inc., a leader in the development of novel therapeutic and preventive vaccines against cancers and infectious diseases, announced today the presentation of recent preclinical data using its next generation of minimally invasive intradermal (skin) electroporation delivery devices at the Phacilitate Vaccine Forum 2011 in Washington, DC.

28 Jan 2011

Inovio to use proceeds from $24.3M offering for development of DNA vaccine against cervical dysplasias

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the closing of the sale to a single institutional investor of 21,130,400 shares of its common stock and warrants to purchase up to 10,565,200 additional shares of its common stock.

28 Jan 2011

USPTO issues Notice of Allowances to Lakewood's three patent applications for treatment of HUS

Lakewood-Amedex, a leading developer of novel anti-infective pharmaceuticals, announced today that the United States Patent and Trademark Office has issued Notice of Allowances on three patent applications relating to the use of novel monoclonal antibodies for the treatment of hemolytic uremic syndrome caused by shiga toxin II secreting E.coli O157: H7 strain.

28 Jan 2011

Reduction in secondhand smoking associated with fewer cases of middle ear infection among children

Harvard School of Public Health (HSPH) researchers and colleagues from Research Institute for a Tobacco Free Society have found that a reduction in secondhand smoking in American homes was associated with fewer cases of otitis media, the scientific name for middle ear infection. The study appears on January 26, 2011, as an online first article on the website of the journal Tobacco Control.

28 Jan 2011

Soligenix and CU enter definitive license agreement for novel vaccine thermostabilization technology

Soligenix, Inc., a late-stage biopharmaceutical company, today announced that it has entered into a definitive license agreement with the University of Colorado (CU) for novel technology for use in the development of subunit vaccines with long-term stability, including stability at elevated temperatures.

28 Jan 2011

Bill Gates, crown prince of Abu Dhabi announce $100m pledge for vaccines for Afghan, Pakistani children

Bill Gates, co-chair of the Bill & Melinda Gates Foundation, and Sheikh Mohammed bin Zayed al-Nahayanm, the crown prince of Abu Dhabi, "pledged $100 million Wednesday to deliver vaccines to children in Afghanistan and Pakistan," Reuters reports.

28 Jan 2011

HIV causes specific subset of CD4+ T-cells to age rapidly: Study

In the early years of the AIDS epidemic, being infected with the virus that causes the disease was considered a virtual death sentence. But with the development of antiretroviral therapy, many with HIV are now living much longer. In fact, it is estimated that by 2015, about half of all HIV-positive individuals will be older than 50.

28 Jan 2011

Tobacco smoke exposure still a major cause for asthma attacks in kids: National Poll

Exposure to smokers is still a major cause of asthma attacks in kids, according to results of a poll released today by the C.S. Mott Children's Hospital National Poll on Children's Health.

28 Jan 2011

Flood-borne diseases make their appearance

In the wake of Queensland’s devastating floods there are warnings to residents, volunteers and others regarding protection against diseases. Australian Medical Association Queensland president-elect Dr Richard Kidd said he expected a number of diseases to appear as a result of people coming in contact with floodwaters and especially the mud left behind.

27 Jan 2011

NQF endorses outcome measures to improve quality of care for people with mental illnesses

The National Quality Forum has endorsed outcome measures to assess the results and thereby improve the quality of care provided to people with mental illnesses. The 4 endorsed mental health measures focus on depression and patients' satisfaction during an inpatient psychiatric hospital stay.

27 Jan 2011

Lancet series examines health issues facing populations in Southeast Asia

"Southeast Asia's 600 million people are facing a raft of new health challenges as the disaster-prone region undergoes some of the world's fastest social change," according to a series of papers and commentary pieces, published Tuesday in the Lancet, Agence France-Presse reports (O'Brien, 1/25).

27 Jan 2011

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Inovio announces regulatory approval for Phase 2 trial to treat leukemia using new vaccine delivery device

$61 million anti-tobacco campaign launched to prevent lung cancer

Research Project's efficient solution for early cancer detection receives Leonardo da Vinci Prize

European Commission grants approval for Johnson & Johnson's proposed acquisition of Crucell

Research roundup: Barriers to trauma care, immunizations; Small business tax credit; Medicare coverage of preventive care

Light therapy can help preserve vocal cord function for patients with early stage laryngeal cancer: Study

Nitrous oxide anesthesia may lead to increased risk of myocardial infarction: Study

Survey finds public lack knowledge of radiotherapy

Tarceva Phase III EURTAC study in NSCLC patients with EGFR activating mutations meets primary endpoint

Preclinical data on Inovio’s intradermal electroporation delivery devices presented at Phacilitate Vaccine Forum

Inovio to use proceeds from $24.3M offering for development of DNA vaccine against cervical dysplasias

USPTO issues Notice of Allowances to Lakewood's three patent applications for treatment of HUS

Reduction in secondhand smoking associated with fewer cases of middle ear infection among children

Soligenix and CU enter definitive license agreement for novel vaccine thermostabilization technology

Bill Gates, crown prince of Abu Dhabi announce $100m pledge for vaccines for Afghan, Pakistani children

HIV causes specific subset of CD4+ T-cells to age rapidly: Study

Tobacco smoke exposure still a major cause for asthma attacks in kids: National Poll

Flood-borne diseases make their appearance

NQF endorses outcome measures to improve quality of care for people with mental illnesses

Lancet series examines health issues facing populations in Southeast Asia

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in